Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
30.09.25
/
50%
€10.60
Target price
30.09.26
€23.89
Performance (%)
-8.96%
Price
12.06.26
€9.70
Summary
This prediction is currently active. With a performance of -8.96%, the BUY prediction by Westpark_Capital is trending in the wrong direction. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -1.020% | -1.020% |
| iShares Core DAX® | 0,27 % | 2,50 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % |
| iShares S&P 500 | 0,15 % | 1,92 % |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.60
02.09.25
02.09.25
€20.51
02.09.26
02.09.26
27.63%
12.06.26
12.06.26
